![](https://www.embl.org/news/wp-content/uploads/2020/01/Araxa_logo-300x206.jpg)
Antibody engineering for therapy and diagnosis
Lab Matters, Science & Technology The new EMBL spinoff company Araxa Biosciences GmbH aims to set new standards for the development of antibody-based therapeutics and diagnostics
2020
lab-mattersscience-technology